Real-world safety profile of therapy with ibrutinib or acalabrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
Saved in:
Main Authors: | Ramsay Hafer, Francesco Iadevaia, Thomas Z. Rohan, Teresa Duong, Maria Poluch, Gina Keiffer, Michael Li, Andres Ferber, Luca Laurenti, Alan S. Khoo, Pierluigi Porcu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Blood Neoplasia |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2950328024000645 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Amebic Encephalitis in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib Therapy
by: Ensi Voshtina, et al.
Published: (2018-01-01) -
Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and T-Prolymphocytic Leukemia Presenting with Lymphocytosis, Skin Lesions, and Generalized Lymphadenopathy
by: Ali Sakhdari, et al.
Published: (2019-01-01) -
Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) with Reed-Sternberg-like cells with no convincing evidence of classic Hodgkin lymphoma
by: Latha K. Abraham, et al.
Published: (2023-07-01) -
Chronic Lymphocytic Leukemia and Myelofibrosis
by: Fares Darawshy, et al.
Published: (2018-01-01) -
Chronic Lymphocytic Leukemia-Associated Cholangiopathy
by: Jake Mann, et al.
Published: (2011-01-01)